A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus

New York

New York

Great Neck

Manhasset

Brooklyn

Roslyn

Mexico City

Rochester

Pittsburgh

Bethlehem

Philadelphia

Cumberland

Hagerstown

Arlington

Winston-Salem

Chapel Hill

Greenville

Charlotte

Charleston

Charleston

Atlanta

Orlando

Aventura

Clearwater

Birmingham

Anniston

Cleveland

Guadalajara

Ann Arbor

Morelia

Chicago

Chicago

Kansas City

Baton Rouge

Oklahoma City

Tulsa

Dallas

Dallas

Houston

Houston

Houston

Sugar Land

San Luis Potosi S.l.p.

Coeur d'Alene

Tucson

Los Angeles

Long Beach

Upland

La Jolla

Palo Alto

San Leandro

Spokane

Moscow

Yaroslavl

Kazan'

Tomsk

Boston

Buenos Aires

Buenos Aires

Ciudad Autonoma Buenos A.

Rosario

San Miguel de Tucumán

Barranquilla

Barranquilla-Atlantico

Bogota D.C.

Bogotá

Bucaramanga

Chia-Cundinamarca

Medellin-Antioquia

Mexico Ctiy

México

Miexico City

Bydgoszcz

Elblag

Gmina Końskie

Kościan

Krakow

Poznan

Warsaw